Hormone replacement therapy following breast cancer

被引:0
|
作者
Kubista, E [1 ]
机构
[1] Univ Vienna, Abt Spezielle Gynakol, Klin Frauenheilkunde, Allgemeines Krankenhaus Wien, A-1090 Vienna, Austria
来源
ONKOLOGIE | 1997年 / 20卷 / 06期
关键词
breast cancer; hormone replacement therapy; prognosis; recurrence;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a common disease with a rising incidence, preferably in peri-and postmenopausal women. Because of improvements in early diagnosis and screening and because of more effective therapy, an increasing number of premenopausal patients with a history of breast cancer will come into the age of menopause, and like all other women they are confronted with its problems and symptoms. Recent reports, indicating an elevated risk of breast cancer by hormone replacement therapy, have stimulated the discussion about its safety and use in breast cancer survivors. Until today no randomized studies have been reported. Available though only preliminary data do not show an adverse effect of hormone replacement therapy (estrogens and gestagens) in breast cancer survivors. These data, however, are weakened by the low number of cases and a short observation time, Due to the fact that these data are not confident enough, an individual strategy is necessary in counselling patients with breast cancer history, The risk of menopausal diseases and/or symptoms have to be balanced against the risk of inducing breast cancer or its recurrence. Therefore, a general medical advice cannot be given at present. Great hope is implemented by the development of new antiestrogen compounds which will protect breast tissue in a selective way, whereas they will exert the beneficial estrogen effects in other organ systems.
引用
收藏
页码:486 / 488
页数:3
相关论文
共 50 条
  • [21] Hormone replacement therapy and breast cancer risk
    Gambrell, RD
    ARCHIVES OF FAMILY MEDICINE, 1996, 5 (06) : 341 - 348
  • [22] Hormone Replacement Therapy After Breast Cancer?
    Holzer I.
    Journal für Gynäkologische Endokrinologie/Österreich, 2023, 33 (3): : 126 - 127
  • [23] Hormone replacement therapy after breast cancer
    Kenemans, P
    Scheele, F
    WOMEN'S HEALTH AND MENOPAUSE: RISK REDUCTION STRATEGIES, 1997, 11 : 233 - 240
  • [24] Risk of breast cancer with hormone replacement therapy
    Michels, KB
    MIDLIFE HEALTH - CURRENT CONCEPTS AND CHALLENGES FOR THE FUTURE, 2002, 1229 : 135 - 141
  • [25] Hormone replacement therapy and risk of breast cancer
    Stadel, BV
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18): : 2360 - 2361
  • [26] Hormone replacement therapy and breast cancer risk
    Koukoulis, GN
    YOUNG WOMAN AT THE RISE OF THE 21ST CENTURY: GYNECOLOGICAL AND REPRODUCTIVE ISSUES IN HEALTH AND DISEASE, 2000, 900 : 422 - 428
  • [27] Hormone replacement therapy and risk of breast cancer
    Ortmann O.
    Treeck O.
    Inwald E.C.
    Emons G.
    Tempfer C.
    best practice onkologie, 2019, 14 (12) : 570 - 579
  • [28] Hormone replacement therapy and breast cancer screening
    Keck, C
    Tempfer, C
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2003, 63 (10) : 999 - 1003
  • [29] HORMONE REPLACEMENT THERAPY AND BREAST-CANCER
    MCEWAN, HP
    PRACTITIONER, 1977, 218 (1308) : 772 - 772
  • [30] Hormone replacement therapy after breast cancer
    Pertynski, T
    Kubasiewicz, M
    Wojciechowski, A
    10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 223 - 229